WHO's Science in 5 #shorts: Older adults and COVID-19 vaccines - 14 October 2022

WHO's Science in 5 #shorts: Older adults and COVID-19 vaccines - 14 October 2022 Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorised Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorised

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.